SHARRIE REYNOLDS: Open Payments
NPI 1083141808 · LEXINGTON, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$770 in 26 payments from 12 companies in 2025. Trend: 2023 $1,829 · 2024 $1,415 · 2025 $770
Food & beverage: $770
| Company | Payments | Amount |
|---|---|---|
| Sumitomo Pharma America, Inc. | 11 | $312 |
| Ferring Pharmaceuticals Inc. | 1 | $164 |
| Medtronic, Inc. | 3 | $67 |
| Endo USA, Inc. | 3 | $64 |
| Verity Pharmaceuticals Inc. | 1 | $35 |
| TOLMAR, INC. | 1 | $29 |
| Astellas Pharma US Inc | 1 | $19 |
| ACCORD HEALTHCARE, INC. | 1 | $19 |
| UROGEN PHARMA, INC. | 1 | $18 |
| Boston Scientific Corporation | 1 | $16 |
Products named: GEMTESA, ADSTILADRIN, XIAFLEX, INTERSTIM, Trelstar, ELIGARD, ORGOVYX, ALTAVIVA.
Industry payments across KY — which companies pay providers there.
